Showing results (3861-3870 of 5,227) with videos related to

Sort By:
Pageof 523
Antiviral Research|July 14, 2024
A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19Ernna H Oliveira, Ana C Monteleone-Cassiano, Lucas Tavares, et al.
Antiviral Research|May 22, 2024
6-Thioguanine inhibits severe fever with thrombocytopenia syndrome virus through suppression of EGR1Na Jiang, Yating He, Jing Wu, et al.
Antiviral Research|May 17, 2024
Cytomegalovirus UL44 protein induces a potent T-cell immune response in miceFrancisco J Mancebo, Marcos Nuévalos, Jaanam Lalchandani, et al.
Antiviral Research|June 23, 2024
Dengue Virus dependence on glucokinase activity and glycolysis Confers Sensitivity to NAD(H) biosynthesis inhibitorsEva Ogire, Laure Perrin-Cocon, Marianne Figl, et al.
Antiviral Research|May 23, 2024
Development of nanoparticle vaccines utilizing designed Fc-binding homo-oligomers and RBD-Fc of SARS-CoV-2Yucai Liang, Weiling Xiao, Yuan Peng, et al.
Antiviral Research|May 21, 2024
JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymeraseBrecht Bonneux, Afzaal Shareef, Sergey Tcherniuk, et al.
Antiviral Research|November 22, 2025
The natural polyphenol proanthocyanidin A2 prevents the in vitro infection of Ebola virus and rabies virus by interfering with the early phases of the replication cycleDenis Pasqual, Ilaria Artusi, Michele Paccagnella, et al.
Antiviral Research|February 4, 2026
Acute Management of Measles: A Systematic Review of Therapeutic StrategiesAmandeep Kaur, Ugo Alaribe, Joseph Varon, et al.
Antiviral Research|December 24, 2025
Nipah virus-derived defective interfering particles generated using non-infectious viral replicon particles confer protective efficacy comparable to those produced with standard full-length infectious virusStephen R Welch, Jessica R Spengler, Sarah C Genzer, et al.
Antiviral Research|May 9, 2024
Characterization of SARS-CoV-2 replication in human H1299/ACE2 cells: A versatile and practical infection model for antiviral research and beyondClarisse Salgado-Benvindo, Ali Tas, Jessika C Zevenhoven-Dobbe, et al.
Pageof 523